Searching News Database: FFR
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 12 Feb 2026
Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro(TM) Diagnostic System
Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro(TM) Diagnostic System
HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
HSMN NewsFeed - 14 Sep 2023
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
HSMN NewsFeed - 19 May 2023
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
HSMN NewsFeed - 1 Dec 2021
Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue
Insightec Announces FDA Clearance For Exablate Prostate To Treat Prostate Tissue
HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
HSMN NewsFeed - 16 Aug 2021
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
HSMN NewsFeed - 20 Jul 2021
Alma, a Sisram Medical Company, Announces FDA Clearance and the U.S. Launch of Alma Hybrid(TM)
Alma, a Sisram Medical Company, Announces FDA Clearance and the U.S. Launch of Alma Hybrid(TM)
HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
HSMN NewsFeed - 8 Mar 2021
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
HSMN NewsFeed - 25 Jan 2021
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
HSMN NewsFeed - 13 Oct 2020
WaveClear, Inc Raises $1.125 Million in Series-A Funding Led by Hunniwell Lake Ventures
WaveClear, Inc Raises $1.125 Million in Series-A Funding Led by Hunniwell Lake Ventures
HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
HSMN NewsFeed - 4 Jun 2020
MedHub AutocathFFR Awarded AMAR Certification, Israel's Medical Device Regulatory Approval
MedHub AutocathFFR Awarded AMAR Certification, Israel's Medical Device Regulatory Approval
HSMN NewsFeed - 27 May 2020
Bausch & Lomb Announces The European Launch Of LuxSmart(TM) And LuxGood(TM) Preloaded Intraocular Lenses
Bausch & Lomb Announces The European Launch Of LuxSmart(TM) And LuxGood(TM) Preloaded Intraocular Lenses
HSMN NewsFeed - 11 Dec 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
HSMN NewsFeed - 17 Oct 2019
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
HSMN NewsFeed - 18 Sep 2019
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
HSMN NewsFeed - 30 Jul 2019
Camber Spine Technologies Announces First Implantation Of SPIRA(R)-O Open Matrix OLIF
Camber Spine Technologies Announces First Implantation Of SPIRA(R)-O Open Matrix OLIF
HSMN NewsFeed - 28 Jun 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
HSMN NewsFeed - 24 Jun 2019
Cerapedics Appoints Patrick O'Connor as Vice President of Clinical and Market Development
Cerapedics Appoints Patrick O'Connor as Vice President of Clinical and Market Development
HSMN NewsFeed - 12 Jun 2019
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
HSMN NewsFeed - 28 May 2019
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
HSMN NewsFeed - 13 Mar 2019
Corin Enters The Orthopedic Robotics Market By Acquiring Surgical Robotic Leader OMNI
Corin Enters The Orthopedic Robotics Market By Acquiring Surgical Robotic Leader OMNI
HSMN NewsFeed - 5 Feb 2019
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
HSMN NewsFeed - 5 Sep 2018
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX(R) 20 Degree Implant
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX(R) 20 Degree Implant
HSMN NewsFeed - 28 Aug 2018
European Society of Cardiology incorporates iFR technology into updated guidelines for revascularization
European Society of Cardiology incorporates iFR technology into updated guidelines for revascularization
HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
HSMN NewsFeed - 22 May 2018
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance
HSMN NewsFeed - 10 Apr 2018
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
HSMN NewsFeed - 31 Jan 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 8 Jun 2017
SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital
SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital
HSMN NewsFeed - 6 Jun 2017
Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye
Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye
HSMN NewsFeed - 24 May 2017
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
HSMN NewsFeed - 11 Apr 2017
Intellijoint Surgical(R) Completes One Thousand Total Hip Replacement Procedures with intellijoint HIP(R)
Intellijoint Surgical(R) Completes One Thousand Total Hip Replacement Procedures with intellijoint HIP(R)
HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
HSMN NewsFeed - 16 Mar 2017
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
HSMN NewsFeed - 1 Mar 2017
Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer
Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer
HSMN NewsFeed - 13 Feb 2017
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of Stable Chest Pain in Patients
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of Stable Chest Pain in Patients
HSMN NewsFeed - 3 Jan 2017
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
HSMN NewsFeed - 22 Dec 2016
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
AirXpanders Receives FDA de novo Clearance for AeroForm(R) Tissue Expander System
HSMN NewsFeed - 13 Dec 2016
Lumendi Receives FDA Clearance to Market DiLumen(TM) for Endolumenal Therapy
Lumendi Receives FDA Clearance to Market DiLumen(TM) for Endolumenal Therapy
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
HSMN NewsFeed - 2 Sep 2016
Avita Medical's Regenerative Skin Technology Significantly Reduces Burn Scars and Healing Time
Avita Medical's Regenerative Skin Technology Significantly Reduces Burn Scars and Healing Time
HSMN NewsFeed - 26 Jul 2016
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
HSMN NewsFeed - 30 Jun 2016
Medline and Medic Management Group Launch New GPO Distribution Partnership
Medline and Medic Management Group Launch New GPO Distribution Partnership
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
HSMN NewsFeed - 18 Mar 2016
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
HSMN NewsFeed - 25 Jan 2016
Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations
Opsens hires George Quinoy as Vice President / General Manager U.S. Commercial Sales & Operations
HSMN NewsFeed - 17 Dec 2015
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
HSMN NewsFeed - 23 Nov 2015
Vertex Appoints Michael J. Parini as Executive Vice President and Chief Legal Officer
Vertex Appoints Michael J. Parini as Executive Vice President and Chief Legal Officer
HSMN NewsFeed - 19 Nov 2015
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
HSMN NewsFeed - 3 Nov 2015
Cerapedics Receives FDA Approval for i-FACTOR(TM) Peptide Enhanced Bone Graft in Cervical Spine Surgery
Cerapedics Receives FDA Approval for i-FACTOR(TM) Peptide Enhanced Bone Graft in Cervical Spine Surgery
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
HSMN NewsFeed - 1 Sep 2015
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
HSMN NewsFeed - 27 Aug 2015
Greatbatch Signs Definitive Agreement to Acquire Lake Region Medical for $1.73 Billion
Greatbatch Signs Definitive Agreement to Acquire Lake Region Medical for $1.73 Billion
HSMN NewsFeed - 29 Jul 2015
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
HSMN NewsFeed - 21 Jul 2015
Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
HSMN NewsFeed - 16 Jun 2015
Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR(TM) PMA Approval
Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR(TM) PMA Approval
HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
HSMN NewsFeed - 15 Dec 2014
Volcano Announces 1,000th System Activated with its iFR(R) (instant wave-Free Ratio(TM)) Modality Worldwide
Volcano Announces 1,000th System Activated with its iFR(R) (instant wave-Free Ratio(TM)) Modality Worldwide
HSMN NewsFeed - 23 Oct 2014
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 22 Oct 2014
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
HSMN NewsFeed - 25 Sep 2014
Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
HSMN NewsFeed - 12 Sep 2014
Volcano to Showcase Two Novel Commercial Products at TCT 2014: SyncVision(R), and the iFR(R) Modality
Volcano to Showcase Two Novel Commercial Products at TCT 2014: SyncVision(R), and the iFR(R) Modality
HSMN NewsFeed - 19 Aug 2014
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
HSMN NewsFeed - 23 Jun 2014
Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs
Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs
HSMN NewsFeed - 17 Apr 2014
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella
HSMN NewsFeed - 16 Apr 2014
Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
HSMN NewsFeed - 14 Apr 2014
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
HSMN NewsFeed - 8 Apr 2014
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
HSMN NewsFeed - 27 Mar 2014
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
HSMN NewsFeed - 24 Jan 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
HSMN NewsFeed - 17 Jan 2014
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
Medtronic CoreValve(R) System Obtains Early FDA Approval on Exceptional Clinical Performance
HSMN NewsFeed - 20 Dec 2013
Endologix Receives IDE Approval for the Nellix(R) EndoVascular Aneurysm Sealing System
Endologix Receives IDE Approval for the Nellix(R) EndoVascular Aneurysm Sealing System
HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
HSMN NewsFeed - 16 Dec 2013
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
HSMN NewsFeed - 20 Nov 2013
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
HSMN NewsFeed - 24 Oct 2013
Boston Scientific Announces Transition Plan For New Chief Financial Officer
Boston Scientific Announces Transition Plan For New Chief Financial Officer
HSMN NewsFeed - 22 Sep 2013
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
HSMN NewsFeed - 13 Jun 2013
First U.S. Center to Treat a Patient with the new CyberKnife(R) M6(TM) System
First U.S. Center to Treat a Patient with the new CyberKnife(R) M6(TM) System
HSMN NewsFeed - 30 Apr 2013
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
HSMN NewsFeed - 1 Apr 2013
Halt Medical Announces Initial Commercial Results; Expanded Launch of Acessa(TM) System
Halt Medical Announces Initial Commercial Results; Expanded Launch of Acessa(TM) System
HSMN NewsFeed - 18 Mar 2013
Lantos Technologies Receives FDA Clearance for its 3D Ear Scanning System
Lantos Technologies Receives FDA Clearance for its 3D Ear Scanning System
HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
HSMN NewsFeed - 25 Feb 2013
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
HSMN NewsFeed - 21 Feb 2013
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
HSMN NewsFeed - 6 Feb 2013
SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
HSMN NewsFeed - 14 Jan 2013
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
HSMN NewsFeed - 20 Dec 2012
Merit Medical Completes Acquisition of Thomas Medical Products, a Unit of GE Healthcare
Merit Medical Completes Acquisition of Thomas Medical Products, a Unit of GE Healthcare
HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
HSMN NewsFeed - 26 Nov 2012
Merit Medical Signs Agreement to Acquire Thomas Medical Products, a Unit of GE Healthcare
Merit Medical Signs Agreement to Acquire Thomas Medical Products, a Unit of GE Healthcare
HSMN NewsFeed - 29 Oct 2012
Sagent Pharmaceuticals Announces the Launch of Leucovorin Calcium for Injection
Sagent Pharmaceuticals Announces the Launch of Leucovorin Calcium for Injection
HSMN NewsFeed - 1 Oct 2012
SafeStitch Medical(R), Inc. Announces Sales of the AMID(TM) Hernia Fixation Device
SafeStitch Medical(R), Inc. Announces Sales of the AMID(TM) Hernia Fixation Device
HSMN NewsFeed - 28 Sep 2012
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and Marketing
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and Marketing
HSMN NewsFeed - 19 Sep 2012
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
HSMN NewsFeed - 27 Aug 2012
SurModics Announces Resignation of Jeffrey Smith from the Board of Directors
SurModics Announces Resignation of Jeffrey Smith from the Board of Directors
HSMN NewsFeed - 14 May 2012
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR
HSMN NewsFeed - 14 May 2012
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
HSMN NewsFeed - 14 Mar 2012
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
HSMN NewsFeed - 5 Jan 2012
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
HSMN NewsFeed - 7 Nov 2011
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
HSMN NewsFeed - 15 Mar 2011
Corindus Announces First Robotic-Assisted PCI Procedures in CorPath(R) PRECISE Clinical Trial
Corindus Announces First Robotic-Assisted PCI Procedures in CorPath(R) PRECISE Clinical Trial
HSMN NewsFeed - 6 Dec 2010
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
HSMN NewsFeed - 29 Oct 2010
CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
HSMN NewsFeed - 19 Oct 2010
Orthofix International Announces Promotion of Jeffrey Schumm To Senior Vice President and General Counsel
Orthofix International Announces Promotion of Jeffrey Schumm To Senior Vice President and General Counsel
HSMN NewsFeed - 5 Oct 2010
Varian Medical Systems and Imris to Co-Develop Revolutionary New MR-Guided Radiation Therapy System
Varian Medical Systems and Imris to Co-Develop Revolutionary New MR-Guided Radiation Therapy System
HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
HSMN NewsFeed - 21 Sep 2010
Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
HSMN NewsFeed - 21 Sep 2010
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
HSMN NewsFeed - 12 Aug 2010
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
HSMN NewsFeed - 27 Jul 2010
St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.
St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.
HSMN NewsFeed - 14 Jul 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
HSMN NewsFeed - 8 Jul 2010
Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial
Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial
HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed - 24 May 2010
Boston Scientific Announces Collaborations on Cardiovascular Imaging Technology With Philips and Siemens
Boston Scientific Announces Collaborations on Cardiovascular Imaging Technology With Philips and Siemens
HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
HSMN NewsFeed - 14 Apr 2010
Sagent Pharmaceuticals Announces FDA Approval of Granisetron Hydrochloride Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Granisetron Hydrochloride Injection, USP
HSMN NewsFeed - 14 Apr 2010
Paul Westberg Joins Versartis as Senior Vice President, Business Development
Paul Westberg Joins Versartis as Senior Vice President, Business Development
HSMN NewsFeed - 12 Apr 2010
Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions
Somaxon Pharmaceuticals Appoints Chief Financial Officer and Announces Senior Leadership Promotions
HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
HSMN NewsFeed - 17 Mar 2010
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
HSMN NewsFeed - 15 Mar 2010
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
HSMN NewsFeed - 12 Mar 2010
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
HSMN NewsFeed - 10 Mar 2010
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
HSMN NewsFeed - 8 Feb 2010
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
HSMN NewsFeed - 25 Jan 2010
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
HSMN NewsFeed - 18 Jan 2010
CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
HSMN NewsFeed - 14 Jan 2010
Cardiovascular Systems Receives Conditional IDE Approval for ORBIT II Coronary Clinical Trial
Cardiovascular Systems Receives Conditional IDE Approval for ORBIT II Coronary Clinical Trial
HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed - 11 Jan 2010
Teleflex Incorporated Names Richard (Randy) Meier Chief Financial Officer
Teleflex Incorporated Names Richard (Randy) Meier Chief Financial Officer
HSMN NewsFeed - 7 Jan 2010
Lycera Appoints Senior Life Sciences Executive William J. Sibold as President and CEO
Lycera Appoints Senior Life Sciences Executive William J. Sibold as President and CEO
HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
HSMN NewsFeed - 28 Oct 2009
Safeguard Scientifics Leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals
Safeguard Scientifics Leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals
HSMN NewsFeed - 13 Oct 2009
Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
HSMN NewsFeed - 25 Aug 2009
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems
HSMN NewsFeed - 19 Aug 2009
Long Beach PET Imaging Center Completes Installation of New State-of-the-Art PET/CT Scanner
Long Beach PET Imaging Center Completes Installation of New State-of-the-Art PET/CT Scanner
HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed - 27 Jul 2009
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
HSMN NewsFeed - 23 Jul 2009
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
HSMN NewsFeed - 29 Jun 2009
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 29 Jun 2009
Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
HSMN NewsFeed - 17 Jun 2009
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
HSMN NewsFeed - 4 Jun 2009
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
HSMN NewsFeed - 28 May 2009
500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
Additional items found! 443
Members Archive contains
443 additional stories matching:
FFR
(Password required)
FFR
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!